Education
About Us
Working with TipRanks
Follow Us
Precipio (PRPO)
:PRPO
Earnings Data
Report Date
May 14, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
0.65Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 31, 2025
|% Change Since: 7.34%
|Next Earnings Date:May 14, 2025
Earnings Call Sentiment|Neutral
Precipio ended 2024 with significant achievements in financial stability, including reaching breakeven and achieving positive cash flow. However, the company faced challenges in the products division due to regulatory and operational hurdles, affecting revenue growth. The reorganization and leadership changes aim to address these issues and drive future growth.Company Guidance
In the Q4 and Year-End 2024 Shareholder Update Conference Call, Precipio's CEO Ilan Danieli announced several key financial achievements and strategic goals for the company. During the fourth quarter, the company achieved positive adjusted EBITDA and positive cash flow, marking a significant milestone towards profitability. Revenue growth was reported at 26% for Q4 and 22% for the full year, with the pathology division surpassing its breakeven point of $1.3 million per month for the second consecutive quarter. The company aims to reach a $25 million run rate in the pathology division by the end of 2025. Despite Q4 product division revenues remaining flat at $700,000 compared to Q3, the company anticipates future growth through improved onboarding processes and addressing challenges such as regulatory changes and lab workflow adjustments. Precipio also detailed a revitalized distribution strategy, expecting a shift towards increased revenue through distributor networks. Additionally, the company plans to enhance market visibility and investor engagement, with a focus on providing management guidance on key financial metrics such as revenue and EBITDA as stability in revenue is achieved.Achieving Breakeven and Profitability
In Q4 2024, Precipio achieved positive adjusted EBITDA and positive cash flow, indicating a significant milestone towards profitability with a strong cash reserve and growth pipeline.
Revenue Growth
Precipio reported a revenue growth of nearly 26% in Q4 2024 compared to the previous year and a full-year revenue growth of close to 22%.
Pathology Division Performance
For the second consecutive quarter, pathology revenues exceeded the breakeven point of $1.3 million per month, with a target to reach a $25 million run rate by the end of 2025.
New Leadership in Products Division
Steve Miller rejoined as Chief Commercial Officer to drive growth in the products division, focusing on both direct sales and enhancing collaboration with distribution partners.
---
PRPO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PRPO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 31, 2025 | $6.27 | $5.65 | -9.89% |
| Nov 18, 2024 | $6.19 | $6.08 | -1.78% |
| Aug 19, 2024 | $5.41 | $5.82 | +7.58% |
| May 15, 2024 | $6.49 | $6.24 | -3.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Precipio (PRPO) report earnings?
Precipio (PRPO) is schdueled to report earning on May 14, 2025, TBA Not Confirmed.
What is Precipio (PRPO) earnings time?
Precipio (PRPO) earnings time is at May 14, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRPO EPS forecast?
Currently, no data Available
---